These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 26779533)

  • 1. Use of Dried Plasma Spots for HIV-1 Viral Load Determination and Drug Resistance Genotyping in Mexican Patients.
    Rodriguez-Auad JP; Rojas-Montes O; Maldonado-Rodriguez A; Alvarez-Muñoz MT; Muñoz O; Torres-Ibarra R; Vazquez-Rosales G; Lira R
    Biomed Res Int; 2015; 2015():240407. PubMed ID: 26779533
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of the performance of Abbott m2000 and Roche COBAS Ampliprep/COBAS Taqman assays for HIV-1 viral load determination using dried blood spots and dried plasma spots in Kenya.
    Zeh C; Ndiege K; Inzaule S; Achieng R; Williamson J; Chih-Wei Chang J; Ellenberger D; Nkengasong J
    PLoS One; 2017; 12(6):e0179316. PubMed ID: 28622370
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HIV-1 drug resistance surveillance using dried whole blood spots.
    Bertagnolio S; Soto-Ramirez L; Pilon R; Rodriguez R; Viveros M; Fuentes L; Harrigan PR; Mo T; Sutherland D; Sandstrom P
    Antivir Ther; 2007; 12(1):107-13. PubMed ID: 17503754
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of a dried blood and plasma collection device, SampleTanker(®), for HIV type 1 drug resistance genotyping in patients receiving antiretroviral therapy.
    Diallo K; Lehotzky E; Zhang J; Zhou Z; de Rivera IL; Murillo WE; Nkengasong J; Sabatier J; Zhang G; Yang C
    AIDS Res Hum Retroviruses; 2014 Jan; 30(1):67-73. PubMed ID: 23944768
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HIV type 1 pol gene diversity and antiretroviral drug resistance mutations in Santos, Brazil.
    de Sa-Filho DJ; Soares Mda S; Candido V; Gagliani LH; Cavaliere E; Diaz RS; Caseiro MM
    AIDS Res Hum Retroviruses; 2008 Mar; 24(3):347-53. PubMed ID: 18327988
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A sensitive in-house RT-PCR genotyping system for combined detection of plasma HIV-1 and assessment of drug resistance.
    Steegen K; Demecheleer E; De Cabooter N; Nges D; Temmerman M; Ndumbe P; Mandaliya K; Plum J; Verhofstede C
    J Virol Methods; 2006 May; 133(2):137-45. PubMed ID: 16375980
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dried blood spot specimens are a suitable alternative sample type for HIV-1 viral load measurement and drug resistance genotyping in patients receiving first-line antiretroviral therapy.
    Rottinghaus EK; Ugbena R; Diallo K; Bassey O; Azeez A; Devos J; Zhang G; Aberle-Grasse J; Nkengasong J; Yang C
    Clin Infect Dis; 2012 Apr; 54(8):1187-95. PubMed ID: 22412066
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High concordance between HIV-1 drug resistance genotypes generated from plasma and dried blood spots in antiretroviral-experienced patients.
    Masciotra S; Garrido C; Youngpairoj AS; McNulty A; Zahonero N; Corral A; Heneine W; de Mendoza C; García-Lerma JG
    AIDS; 2007 Nov; 21(18):2503-11. PubMed ID: 18025887
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dried fluid spots for HIV type-1 viral load and resistance genotyping: a systematic review.
    Hamers RL; Smit PW; Stevens W; Schuurman R; Rinke de Wit TF
    Antivir Ther; 2009; 14(5):619-29. PubMed ID: 19704164
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of different RNA extraction methods and storage conditions of dried plasma or blood spots for human immunodeficiency virus type 1 RNA quantification and PCR amplification for drug resistance testing.
    Monleau M; Montavon C; Laurent C; Segondy M; Montes B; Delaporte E; Boillot F; Peeters M
    J Clin Microbiol; 2009 Apr; 47(4):1107-18. PubMed ID: 19193835
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlation between HIV-1 viral load quantification in plasma, dried blood spots, and dried plasma spots using the Roche COBAS Taqman assay.
    Andreotti M; Pirillo M; Guidotti G; Ceffa S; Paturzo G; Germano P; Luhanga R; Chimwaza D; Mancini MG; Marazzi MC; Vella S; Palombi L; Giuliano M
    J Clin Virol; 2010 Jan; 47(1):4-7. PubMed ID: 19962936
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A sensitive genotyping assay for detection of drug resistance mutations in reverse transcriptase of HIV-1 subtypes B and C in samples stored as dried blood spots or frozen RNA extracts.
    Ziemniak C; George-Agwu A; Moss WJ; Ray SC; Persaud D
    J Virol Methods; 2006 Sep; 136(1-2):238-47. PubMed ID: 16828172
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A validated in-house assay for HIV drug resistance mutation surveillance from dried blood spot specimens.
    Neufeld B; Munyuza C; Reimer A; Capiña R; Lee ER; Becker M; Sandstrom P; Ji H; Cholette F
    J Virol Methods; 2024 Jun; 327():114939. PubMed ID: 38604585
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of storage conditions of dried plasma and blood spots on HIV-1 RNA quantification and PCR amplification for drug resistance genotyping.
    Monleau M; Butel C; Delaporte E; Boillot F; Peeters M
    J Antimicrob Chemother; 2010 Aug; 65(8):1562-6. PubMed ID: 20542904
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Co-circulation HIV-1 subtypes B, C, and CRF31_BC in a drug-naïve population from Southernmost Brazil: analysis of primary resistance mutations.
    de Medeiros RM; Junqueira DM; Matte MC; Barcellos NT; Chies JA; Matos Almeida SE
    J Med Virol; 2011 Oct; 83(10):1682-8. PubMed ID: 21837783
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dried plasma/blood spots for monitoring antiretroviral treatment efficacy and pharmacokinetics: a cross-sectional study in rural Burundi.
    Calcagno A; Motta I; Milia MG; Rostagno R; Simiele M; Libanore V; Fontana S; D'Avolio A; Ghisetti V; Di Perri G; Bonora S
    Br J Clin Pharmacol; 2015 May; 79(5):801-8. PubMed ID: 25377591
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of dried blood spots for human immunodeficiency virus type 1 drug resistance testing.
    McNulty A; Jennings C; Bennett D; Fitzgibbon J; Bremer JW; Ussery M; Kalish ML; Heneine W; García-Lerma JG
    J Clin Microbiol; 2007 Feb; 45(2):517-21. PubMed ID: 17166967
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development and optimization of an internally controlled dried blood spot assay for surveillance of human immunodeficiency virus type-1 drug resistance.
    Buckton AJ; Bissett SL; Myers RE; Beddows S; Edwards S; Cane PA; Pillay D
    J Antimicrob Chemother; 2008 Dec; 62(6):1191-8. PubMed ID: 18927229
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rapid decline in the efficiency of HIV drug resistance genotyping from dried blood spots (DBS) and dried plasma spots (DPS) stored at 37 degrees C and high humidity.
    García-Lerma JG; McNulty A; Jennings C; Huang D; Heneine W; Bremer JW
    J Antimicrob Chemother; 2009 Jul; 64(1):33-6. PubMed ID: 19403653
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Feasibility of using dried blood spots to detect HIV drug resistance genotyping].
    Ma PF; Xing H; Liao LJ; Chen B; Zhao QB; Quan Y; Sun F; Yang SM; Su B; Chen X; Shao YM
    Zhonghua Yu Fang Yi Xue Za Zhi; 2010 Nov; 44(11):993-8. PubMed ID: 21215126
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.